Elio Gregory Pizzutilo

1.3k total citations
18 papers, 651 citations indexed

About

Elio Gregory Pizzutilo is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Elio Gregory Pizzutilo has authored 18 papers receiving a total of 651 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 13 papers in Pulmonary and Respiratory Medicine and 6 papers in Molecular Biology. Recurrent topics in Elio Gregory Pizzutilo's work include Lung Cancer Treatments and Mutations (11 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Cancer Genomics and Diagnostics (5 papers). Elio Gregory Pizzutilo is often cited by papers focused on Lung Cancer Treatments and Mutations (11 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Cancer Genomics and Diagnostics (5 papers). Elio Gregory Pizzutilo collaborates with scholars based in Italy, Switzerland and Japan. Elio Gregory Pizzutilo's co-authors include Andrea Sartore‐Bianchi, Salvatore Siena, Federica Tosi, Alessio Amatu, Katia Bencardino, Diego Signorelli, Lorenzo Ruggieri, Fausto Petrelli, Giuseppina Dognini and Gianluca Tomasello and has published in prestigious journals such as Cancer Research, Clinical Cancer Research and Annals of Oncology.

In The Last Decade

Elio Gregory Pizzutilo

18 papers receiving 640 citations

Peers

Countries citing papers authored by Elio Gregory Pizzutilo

Since Specialization

Citations

This map shows the geographic impact of Elio Gregory Pizzutilo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elio Gregory Pizzutilo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elio Gregory Pizzutilo more than expected).

Fields of papers citing papers by Elio Gregory Pizzutilo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elio Gregory Pizzutilo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elio Gregory Pizzutilo. The network helps show where Elio Gregory Pizzutilo may publish in the future.

Co-authorship network of co-authors of Elio Gregory Pizzutilo

This figure shows the co-authorship network connecting the top 25 collaborators of Elio Gregory Pizzutilo. A scholar is included among the top collaborators of Elio Gregory Pizzutilo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elio Gregory Pizzutilo. Elio Gregory Pizzutilo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Biphenotypic lung carcinoma with coexpression of TTF-1 and ΔNP63/P40 within most of the same individual cells: a further case confirming poor prognosis and a review of literature 2024 ·Pathologica ·Alessandro Marando, (unknown), (unknown), Emanuele Valtorta, Calogero Lauricella, Valentina Motta, Silvio Veronese, Giulio Cerea, Laura Giannetta, (unknown), Diego Signorelli, Elio Gregory Pizzutilo, Emanuela Bonoldi, Giuseppe Pelosi	1
2	A systematic review and meta-analysis on the optimal treatment duration of checkpoint inhibitoRS in solid tumors: The OTHERS study 2023 ·Critical Reviews in Oncology/Hematology ·Giorgio Bogani, Michela Cinquini, Diego Signorelli, Elio Gregory Pizzutilo, (unknown), Melissa Bersanelli, Daniele Raggi, Salvatore Alfieri, Sebastiano Buti, Federica Bertolini, Pierluigi Bonomo, Laura Marandino, Mimma Rizzo, Marta Monteforte, Marco Maria Aiello, Antonino Carmelo Tralongo, Valter Torri, Violante Di Donato, Patrizia Giannatempo	15
3	Repotrectinib Overcomes F2004V Resistance Mutation in ROS1-Rearranged NSCLC: A Case Report 2023 ·JTO Clinical and Research Reports ·Elio Gregory Pizzutilo, (unknown), (unknown), (unknown), Valentina Motta, Calogero Lauricella, Giovanna Marrapese, Giulio Cerea, Diego Signorelli, Silvio Veronese, Laura Giannetta, Andrea Sartore‐Bianchi, Salvatore Siena	5
4	Circulating Tumor DNA to Drive Treatment in Metastatic Colorectal Cancer 2023 ·Clinical Cancer Research ·Giorgio Patelli, Gianluca Mauri, Federica Tosi, Alessio Amatu, Katia Bencardino, Erica Bonazzina, Elio Gregory Pizzutilo, Federica Villa, (unknown), (unknown), (unknown), (unknown), Giovanni Crisafulli, Federica Di Nicolantonio, Silvia Marsoni, Alberto Bardelli, Salvatore Siena, Andrea Sartore‐Bianchi	23
5	Immune Checkpoint Inhibitors and the Exposome: Host-Extrinsic Factors Determine Response, Survival, and Toxicity 2023 ·Cancer Research ·Elio Gregory Pizzutilo, (unknown), (unknown), (unknown), (unknown), (unknown), Laura Giannetta, Giulio Cerea, Diego Signorelli, Salvatore Siena, Andrea Sartore‐Bianchi	9
6	What to do after immune-checkpoint inhibitors failure in advanced non-small cell lung cancer: an expert opinion and review 2023 ·Expert Review of Respiratory Medicine ·(unknown), (unknown), Federica Villa, (unknown), (unknown), Francesca Martinelli, (unknown), (unknown), (unknown), Alessandro Marando, Andrea Sartore‐Bianchi, Laura Giannetta, Giulio Cerea, Salvatore Siena, Elio Gregory Pizzutilo, Diego Signorelli	1
7	Moving Immune Checkpoint Inhibitors to Early Non-Small Cell Lung Cancer: A Narrative Review 2022 ·Cancers ·Giuseppe Viscardi, Fabiana Vitiello, Alberto Servetto, Valerio Gristina, Elio Gregory Pizzutilo, (unknown), (unknown), (unknown), (unknown), (unknown), Luigi Aronne, (unknown), Filomena Napolitano, (unknown), Francesca Caputo, (unknown), (unknown), (unknown), Danilo Rocco, Vincenzo Montesarchio	4
8	Application of histology-agnostic treatments in metastatic colorectal cancer 2022 ·Digestive and Liver Disease ·Andrea Sartore‐Bianchi, (unknown), Giorgio Patelli, Gianluca Mauri, Elio Gregory Pizzutilo, Salvatore Siena	7
9	The predictive role of ERBB2 point mutations in metastatic colorectal cancer: A systematic review 2022 ·Cancer Treatment Reviews ·(unknown), Gianluca Mauri, (unknown), Giorgio Patelli, Elio Gregory Pizzutilo, Yoshiaki Nakamura, Takayuki Yoshino, Salvatore Siena, Andrea Sartore‐Bianchi	12
10	Pneumatosis Intestinalis Induced by Anticancer Treatment: A Systematic Review 2022 ·Cancers ·(unknown), Federica Villa, Federica Tosi, Elio Gregory Pizzutilo, (unknown), (unknown), (unknown), Giulia Fornasier, (unknown), (unknown), Giulia Mosini, Arianna Pani, Salvatore Siena, Francesco Scaglione, Andrea Sartore‐Bianchi	15
11	Liquid Biopsy for Small Cell Lung Cancer either De Novo or Transformed: Systematic Review of Different Applications and Meta-Analysis 2021 ·Cancers ·Elio Gregory Pizzutilo, (unknown), Alessio Amatu, Lorenzo Ruggieri, Calogero Lauricella, Silvio Veronese, Diego Signorelli, Giulio Cerea, Laura Giannetta, Salvatore Siena, Andrea Sartore‐Bianchi	20
12	Immune checkpoint inhibitors for unresectable malignant pleural mesothelioma 2021 ·Human Vaccines & Immunotherapeutics ·Giulio Metro, Diego Signorelli, Elio Gregory Pizzutilo, Laura Giannetta, Giulio Cerea, (unknown), Alex Friedlaender, Alfredo Addeo, Martina Mandarano, Guido Bellezza, Fausto Roila	8
13	Entrectinib for the treatment of metastatic NSCLC: safety and efficacy 2020 ·Expert Review of Anticancer Therapy ·Andrea Sartore‐Bianchi, Elio Gregory Pizzutilo, Giovanna Marrapese, Federica Tosi, Giulio Cerea, Salvatore Siena	28
14	Association of Steroids Use with Survival in Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis 2020 ·Cancers ·Fausto Petrelli, Diego Signorelli, Michele Ghidini, Antonio Ghidini, Elio Gregory Pizzutilo, Lorenzo Ruggieri, Mary Cabiddu, Karen Borgonovo, Giuseppina Dognini, Matteo Brighenti, Alessandro De Toma, Erika Rijavec, Marina Chiara Garassino, Francesco Grossi, Gianluca Tomasello	207
15	Liquid biopsy for rectal cancer: A systematic review 2019 ·Cancer Treatment Reviews ·Daniela Massihnia, Elio Gregory Pizzutilo, Alessio Amatu, Federica Tosi, Silvia Ghezzi, Katia Bencardino, (unknown), (unknown), Giorgio Patelli, Francesco Scaglione, Angelo Vanzulli, Salvatore Siena, Andrea Sartore‐Bianchi	25
16	Tropomyosin receptor kinase (TRK) biology and the role of NTRK gene fusions in cancer 2019 ·Annals of Oncology ·Alessio Amatu, Andrea Sartore‐Bianchi, Katia Bencardino, Elio Gregory Pizzutilo, Federica Tosi, Salvatore Siena	204
17	Concurrent Small-Cell Transformation and Emergence of Trans-C797S and T790M Mutations Under Sequential Treatment With EGFR Inhibitors in Lung Adenocarcinoma 2019 ·JCO Precision Oncology ·Elio Gregory Pizzutilo, Calogero Lauricella, Giulio Cerea, Laura Giannetta, Gianluca Tomasello, (unknown), Valentina Motta, (unknown), Francesco Scaglione, Angelo Vanzulli, Massimo Torre, Emanuela Bonoldi, Silvio Veronese, Salvatore Siena, Andrea Sartore‐Bianchi	2
18	Retreatment with anti-EGFR monoclonal antibodies in metastatic colorectal cancer: Systematic review of different strategies 2018 ·Cancer Treatment Reviews ·Gianluca Mauri, Elio Gregory Pizzutilo, Alessio Amatu, Katia Bencardino, Laura Palmeri, Erica Bonazzina, Federica Tosi, G Stella, Giovanni Burrafato, Francesco Scaglione, Silvia Marsoni, Giulia Siravegna, Alberto Bardelli, Salvatore Siena, Andrea Sartore‐Bianchi	65

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact